Cherradi N, Brandenburger Y, Rossier M F, Vallotton M B, Stocco D M, Capponi A M
Division of Endocrinology and Diabetology, Faculty of Medicine, Geneva, Switzerland.
Mol Endocrinol. 1998 Jul;12(7):962-72. doi: 10.1210/mend.12.7.0132.
Atrial natriuretic peptide (ANP) is a potent inhibitor of mineralocorticoid synthesis induced in adrenal glomerulosa cells by physiological agonists activating the calcium messenger system, such as angiotensin II (Ang II) and potassium ion (K+). While the role of calcium in mediating Ang II- and K(+)-induced aldosterone production is clearly established, the mechanisms leading to blockade of this steroidogenic response by ANP remain obscure. We have used bovine adrenal zona glomerulosa cells in primary culture, in which an activation of the calcium messenger system was mimicked by a 2-h exposure to an intracellular high-calcium clamp. The effect of ANP was studied on the following parameters of the steroidogenic pathway: 1) pregnenolone and aldosterone production; 2) changes in cytosolic ([Ca2+]c) and mitochondrial ([Ca2+]m) Ca2+ concentrations, as assessed with targeted recombinant aequorin; 3) cholesterol content in outer mitochondrial membranes (OM), contact sites (CS), and inner membranes (IM); 4) steroidogenic acute regulatory (StAR) protein import into mitochondria by Western blot analysis; 5) StAR protein synthesis, as determined by [35S]methionine incorporation, immunoprecipitation, and SDS-PAGE; 6) StAR mRNA levels by Northern blot analysis with a StAR cDNA; 7) StAR gene transcription by nuclear run-on analysis. While clamping Ca2+ at 950 nM raised pregnenolone output 3.5-fold and aldosterone output 3-fold, ANP prevented these responses with an IC50 of 1 nM and a maximal effect of 90% inhibition at 10 nM. In contrast, ANP did not affect the [Ca2+]c or [Ca2+]m changes occurring under Ca2+ clamp or Ang II stimulation in glomerulosa cells. The accumulation of cholesterol content in CS (139.7 +/- 10.7% of control) observed under high-Ca2+ clamp was prevented by 10 nM ANP (92.4 +/- 4% of control). Similarly, while Ca2+ induced a marked accumulation of StAR protein in mitochondria of glomerulosa cells to 218 +/- 44% (n = 3) of controls, the presence of ANP led to a blockade of StAR protein mitochondrial import (113.3 +/- 15.0%). This effect was due to a complete suppression of the increased [35S]methionine incorporation into StAR protein that occurred under Ca2+ clamp (94.5 +/- 12.8% vs. 167.5 +/- 17.3%, n = 3). Furthermore, while the high-Ca2+ clamp significantly increased StAR mRNA levels to 188.5 +/- 8.4 of controls (n = 4), ANP completely prevented this response. Nuclear run-on analysis showed that increases in intracellular Ca2+ resulted in transcriptional induction of the StAR gene and that ANP inhibited this process. These results demonstrate that Ca2+ exerts a transcriptional control on StAR protein expression and that ANP appears to elicit its inhibitory effect on aldosterone biosynthesis by acting as a negative physiological regulator of StAR gene expression.
心房利钠肽(ANP)是一种强效抑制剂,可抑制生理激动剂激活钙信使系统后在肾上腺球状带细胞中诱导的盐皮质激素合成,这些生理激动剂如血管紧张素II(Ang II)和钾离子(K+)。虽然钙在介导Ang II和K+诱导的醛固酮生成中的作用已明确确立,但ANP阻断这种类固醇生成反应的机制仍不清楚。我们使用原代培养的牛肾上腺球状带细胞,通过2小时暴露于细胞内高钙钳制来模拟钙信使系统的激活。研究了ANP对类固醇生成途径以下参数的影响:1)孕烯醇酮和醛固酮生成;2)用靶向重组水母发光蛋白评估的胞质([Ca2+]c)和线粒体([Ca2+]m)钙浓度变化;3)线粒体外膜(OM)、接触位点(CS)和内膜(IM)中的胆固醇含量;4)通过蛋白质免疫印迹分析检测类固醇生成急性调节(StAR)蛋白导入线粒体的情况;5)通过[35S]甲硫氨酸掺入、免疫沉淀和SDS-PAGE测定StAR蛋白合成;6)用StAR cDNA通过Northern印迹分析检测StAR mRNA水平;7)通过核转录分析检测StAR基因转录。当将Ca2+钳制在950 nM时,孕烯醇酮产量提高3.5倍,醛固酮产量提高3倍,而ANP以1 nM的IC50阻止这些反应,在10 nM时最大抑制效果达90%。相反,ANP不影响球状带细胞在Ca2+钳制或Ang II刺激下发生的[Ca2+]c或[Ca2+]m变化。在高钙钳制下观察到的CS中胆固醇含量积累(为对照的139.7±10.7%)被10 nM ANP阻止(为对照的92.4±4%)。同样,虽然Ca2+诱导球状带细胞线粒体中StAR蛋白显著积累至对照的218±44%(n = 3),但ANP的存在导致StAR蛋白线粒体导入受阻(为113.3±15.0%)。这种作用是由于完全抑制了在Ca2+钳制下[35S]甲硫氨酸掺入StAR蛋白的增加(94.5±12.8%对167.5±17.3%,n = 3)。此外,虽然高钙钳制显著提高StAR mRNA水平至对照的188.5±8.4(n = 4),但ANP完全阻止了这种反应。核转录分析表明,细胞内Ca2+增加导致StAR基因转录诱导,而ANP抑制了这一过程。这些结果表明,Ca2+对StAR蛋白表达发挥转录控制作用,且ANP似乎通过作为StAR基因表达的负性生理调节因子对醛固酮生物合成产生抑制作用。